Last reviewed · How we verify
pyroglutamate rongliflozin capsules
pyroglutamate rongliflozin capsules is a Small molecule drug developed by Sunshine Lake Pharma Co., Ltd.. It is currently in Phase 1 development.
At a glance
| Generic name | pyroglutamate rongliflozin capsules |
|---|---|
| Sponsor | Sunshine Lake Pharma Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Pyroglutamate Rongliflozin Capsules in Subjects With Mild and Moderate Liver Damage (PHASE1)
- A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Rongliflozin in Type 2 Diabetic Subjects With Renal Impairment (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- pyroglutamate rongliflozin capsules CI brief — competitive landscape report
- pyroglutamate rongliflozin capsules updates RSS · CI watch RSS
- Sunshine Lake Pharma Co., Ltd. portfolio CI
Frequently asked questions about pyroglutamate rongliflozin capsules
What is pyroglutamate rongliflozin capsules?
pyroglutamate rongliflozin capsules is a Small molecule drug developed by Sunshine Lake Pharma Co., Ltd..
Who makes pyroglutamate rongliflozin capsules?
pyroglutamate rongliflozin capsules is developed by Sunshine Lake Pharma Co., Ltd. (see full Sunshine Lake Pharma Co., Ltd. pipeline at /company/sunshine-lake-pharma-co-ltd).
What development phase is pyroglutamate rongliflozin capsules in?
pyroglutamate rongliflozin capsules is in Phase 1.